TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong · Delayed Price · Currency is HKD 38.52
-0.18 (-0.47%)
May 28, 2026, 9:30 AM HKT
HKG:2617 Market Cap
HKG:2617 has a market cap or net worth of 15.64 billion as of May 27, 2026.
Market Cap
15.64B
Enterprise Value
15.10B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
38.52
Market Cap Chart
Since June 23, 2025, HKG:2617's market cap has increased from 9.33B to 15.64B, an increase of 67.66%. That is a compound annual growth rate of 75.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 16.41B | -64.01% |
| Dec 31, 2025 | 45.60B | 388.94% |
| Jun 23, 2025 | 9.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InnoCare Pharma | 24.45B |
| Duality Biotherapeutics | 19.59B |
| Metis TechBio | 18.87B |
| Keymed Biosciences | 17.82B |
| Zai Lab | 16.24B |
| Ascletis Pharma | 15.55B |
| Ascentage Pharma Group International | 14.52B |
| Nanjing Leads Biolabs | 12.42B |